HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Rhea-AI Summary
Harmony Biosciences Holdings (Nasdaq: HRMY) has announced its management team's participation in two upcoming investor conferences in December 2024. The company will attend Citi's 2024 Global Healthcare Conference in Miami on Tuesday, December 3, and the Piper Sandler 36th Annual Healthcare Conference in New York City on Wednesday, December 4, at 8:30 a.m. ET. A fireside chat at the Piper Sandler conference will be webcast and available for viewing on Harmony's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, HRMY gained 1.34%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Citi's 2024 Global Healthcare Conference
- Location: Miami
- Tuesday, December 3, 2024
Piper Sandler 36th Annual Healthcare Conference
- Location: New York City
- Fireside Chat: Wednesday, December 4, 2024, at 8:30 a.m., ET
A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-302312218.html
SOURCE Harmony Biosciences